Suboptimal glycaemic control enhances the risk of impaired prothrombotic state in youths with type 1 diabetes mellitus

Diab Vasc Dis Res. 2014 May;11(3):208-16. doi: 10.1177/1479164114528821. Epub 2014 Mar 25.

Abstract

Objective: To estimate markers of prothrombotic state and endothelial dysfunction in youths with type 1 diabetes mellitus (T1DM) and investigate possible associations with anthropometric/demographic data, glycaemic control and lipid profile.

Methods: In a cross-sectional design, we recruited 155 youths with T1DM and determined levels of plasminogen activator inhibitor-1-antigen (PAI-1-Ag), von Willebrand factor-antigen (vWF-Ag), fibrinogen (FB), lipids and glycosylated haemoglobin (HbA1c).

Results: Of all the participants, 76 (49%) had increased levels of at least one of prothrombotic factors. Suboptimal glycaemic control was associated with a worse lipid profile and an eightfold increased risk of elevated vWF-Ag levels. Higher vWF-Ag concentrations were also correlated with impaired lipid profile and increased HbA1c values, whereas PAI-1-Ag was positively correlated only with triglyceride levels. After adjustment for potential confounders, only HbA1c contributed independently to the variation in vWF-Ag levels.

Conclusion: Impaired prothrombotic state and consequently endothelial dysfunction are present in youths with T1DM, representing a cumulative risk factor for future cardiovascular disease (CVD). Achievement and maintenance of euglycaemia and normolipidaemia are crucial to decelerate progress of this process.

Keywords: Children and adolescents; fibrinogen; plasminogen activator inhibitor-1-antigen; type 1 diabetes mellitus; von Willebrand factor-antigen.

MeSH terms

  • Adolescent
  • Child
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 1 / blood*
  • Diabetes Mellitus, Type 1 / complications
  • Female
  • Fibrinogen / metabolism*
  • Glycated Hemoglobin / metabolism*
  • Humans
  • Male
  • Plasminogen Activator Inhibitor 1 / blood*
  • Thrombophilia / blood*
  • Thrombophilia / complications
  • von Willebrand Factor / metabolism*

Substances

  • Glycated Hemoglobin A
  • Plasminogen Activator Inhibitor 1
  • SERPINE1 protein, human
  • hemoglobin A1c protein, human
  • von Willebrand Factor
  • Fibrinogen